A recent report published by Nova one advisor states that the global Multiplex Detection Immunoassays market, which stood at US$ 1.8 Billion in 2020 is anticipated to reach US$ 3.7 Billion by 2030, exhibiting progressive at 9.7% CAGR between 2022 and 2030.
read more..